Clinically used drug arsenic trioxide targets XIAP and overcomes apoptosis resistance in an organoid-based preclinical cancer modelLiwa Shi(Sun Yat-sen University), Xinming Yang(Chinese Academy of Sciences)Chemical ScienceJanuary 1, 202410.1039/d4sc01294aCited by 9SaveCiteExport RISWatch citationsRelated PapersEasy synthesis of highly fluorescent carbon quantum dots from gelatin and their luminescent properties and applications|Carbon|2013|656